Bausch Health Companies Inc (BHC) Stock Analysis

Bausch Health Companies Inc (BHC) is a publicly traded company in the HEALTHCARE sector. It trades at $5.01, carries a market capitalization of $1.98B. This page summarizes the public market data, fundamentals, and frequently asked questions for BHC, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NYSE

Key Metrics

Market Sentiment

Bausch Health Companies Inc currently has a Bullish sentiment score of 0.44.

About Bausch Health Companies Inc

Bausch Health Companies Inc. (BHC) is a prominent global player in the development, manufacturing, and marketing of a broad range of pharmaceutical, medical device, and over-the-counter (OTC) products, emphasizing specialties such as eye health, gastroenterology, and dermatology. Based in Laval, Canada, the company utilizes its diverse portfolio to meet significant medical needs and improve patients' quality of life globally. Bausch Health's strategic focus on innovation and growth fosters a ...

GNG Research Analysis

GNG Research scores Bausch Health Companies Inc (BHC) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for BHC.

Frequently Asked Questions

Does BHC pay dividends?

Bausch Health Companies Inc (BHC) does not currently pay a regular dividend.

What is BHC's market cap?

Bausch Health Companies Inc (BHC) has a market capitalization of $1.98B with a current stock price of $5.01.